[H-3] NALOXONE AS AN OPIOID RECEPTOR LABEL - ANALYSIS OF BINDING-SITE HETEROGENEITY AND USE FOR DETERMINATION OF OPIOID AFFINITIES OF CASOMORPHIN ANALOGS

被引：0

作者：

SCHNITTLER, M

LIEBMANN, C

SCHRADER, U

SCHULZE, HP

NEUBERT, K

REPKE, H

机构：

[1] UNIV JENA,DEPT BIOL,DIV BIOCHEM,O-6900 JENA,GERMANY

[2] UNIV JENA,INST PATHOL BIOCHEM,O-6900 JENA,GERMANY

[3] MARTIN LUTHER UNIV,DEPT BIOTECHNOL,O-4010 HALLE,GERMANY

[4] HUMBOLDT UNIV,BEREICH MED CHARITE,INST PHARMACOL & TOXICOL,O-1040 BERLIN,GERMANY

来源：

BIOMEDICA BIOCHIMICA ACTA | 1990年 / 49卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：209 / 218

页数：10

共 50 条

[21] PHARMACOLOGICAL CHARACTERIZATION OF THE LOCUST NEURONAL H-3 MIANSERIN BINDING-SITE, A PUTATIVE HISTAMINE-RECEPTOR
ROEDER, T
VOSSFELDT, R
GEWECKE, M
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1993, 106 (02): : 503 - 507
[22] DETAILED ANALYSIS OF HETEROGENEITY OF [H-3] NALOXONE BINDING-SITES IN RAT-BRAIN SYNAPTOSOMES
SZUCS, M
BORSODI, A
BOGDANY, A
GAAL, J
BATKE, J
TOTH, G
NEUROCHEMICAL RESEARCH, 1987, 12 (07) : 581 - 587
[23] [H-3] METHYL-AZIDO-BUPIVACAINE (H-3-MAB) PHOTOLABELS THE ACETYLCHOLINE BINDING-SITE OF THE NICOTINIC RECEPTOR
WANG, L
DIPAOLA, M
KARLIN, A
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1988, 196 : 112 - ORGN
[24] THE SOLUBILIZED LOCUST NEURONAL H-3 MIANSERIN BINDING-SITE, A HISTAMINE H-1-LIKE RECEPTOR MOLECULE
ROEDER, T
VOSSFELDT, R
GEWECKE, M
INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 25 (09) : 1049 - 1054
[25] LEUCINE ENKEPHALIN NONCOMPETITIVELY INHIBITS THE BINDING OF [H-3] NALOXONE TO THE OPIATE MU-RECOGNITION SITE - EVIDENCE FOR DELTA-]MU BINDING-SITE INTERACTIONS INVITRO
ROTHMAN, RB
DANKS, JA
JACOBSON, AE
BURKE, TR
RICE, KC
NEUROPEPTIDES, 1985, 6 (04) : 351 - 363
[26] [H-3] ETHYLKETOCYCLAZOCINE BINDING TO MOUSE-BRAIN MEMBRANES - EVIDENCE FOR A KAPPA-OPIOID RECEPTOR TYPE
GARZON, J
SANCHEZBLAZQUEZ, P
LEE, NM
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1984, 231 (01) : 33 - 37
[27] COMPUTER-ASSISTED ANALYSIS OF RECEPTOR-BINDING STUDIES OF [H-3] NALOXONE AND [H-3] DADL - A REINTERPRETATION OF THE NA+ EFFECT
LOEW, GH
TOLL, L
KEYS, C
LIFE SCIENCES, 1983, 33 : 163 - 166
[28] LONG-TERM TREATMENT WITH NOMIFENSINE OR LITHIUM DOES NOT CHANGE H-3 NALOXONE BINDING TO OPIOID RECEPTORS IN RAT-BRAIN
CHRISTENSEN, CB
KLYSNER, R
GEISLER, A
ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 (02): : 158 - 160
[29] DOES THE [H-3] MEPYRAMINE BINDING-SITE REPRESENT THE HISTAMINE H-1 RECEPTOR - REEXAMINATION OF THE HISTAMINE H-1 RECEPTOR WITH QUININE
LIU, YQ
HORIO, Y
FUJIMOTO, K
FUKUI, H
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 268 (02) : 959 - 964
[30] OPIOID RECEPTOR LABELING WITH THE CHLOROMETHYL KETONE DERIVATIVE OF [H-3] TYR-D-ALA-GLY-(ME)PHE-GLY-OL (DAMGO) .2. COVALENT LABELING OF MU-OPIOID BINDING-SITE BY H-3 TYR-D-ALA-GLY-(ME)PHE CHLOROMETHYL KETONE
OKTEM, HA
MOITRA, J
BENYHE, S
TOTH, G
LAJTHA, A
BORSODI, A
LIFE SCIENCES, 1991, 48 (18) : 1763 - 1768

← 1 2 3 4 5 →